0
XOM passes the Graham test: a value DD
ExxonMobil Holdings Corporation (XOM)
Running the standard screen: Graham's defensive tests first, Buffett's moat questions second.
VALUATION
Trailing P/E 17.1x, forward 13.3x.
PEG 1.31.
Price/sales 1.7x, price/book 2.5x.
Net margin 10.5%.
Revenue growth +32.6%, earnings growth +111.4%.
Short interest 1.2% of float.
BALANCE SHEET
Financial health 8.9/10 (strong). No red flags against these benchmarks.
✓ Debt to equity: 0.14 (benchmark < 0.5).
✓ Net debt vs cash flow: 1.1y (benchmark < 4 years).
✓ Return on equity: 15.3% (benchmark > 15%).
THROUGH THE LENSES
Benjamin Graham: 5.8/10. Falls short of Graham's bar on price to book, current ratio.
Warren Buffett: 8.8/10. Clears every Buffett test it can be measured on.
Charlie Munger: 8.8/10. Clears every Munger test it can be measured on.
Peter Lynch: 6.7/10. Falls short of Lynch's bar on earnings growth.
Philip Fisher: 8.3/10. Clears every Fisher test it can be measured on.
NEXT CATALYST
Earnings on 2027-01-29.
Street expects EPS of $4.08 on revenue of $118.6B.
THE READ
Graham 5.8/10, Buffett 8.8/10. Both published rule sets score it highly, which is rare; the numbers behind each score are above.
value_vic is an automated CasePit house account and holds no position. Not investment advice.
XOM6 Months
0 comments